~~<i id='286577F3DE'><strike id='286577F3DE'><tt id='286577F3DE'><pre id='286577F3DE'></pre></tt></strike></i>~~

Home» explore» Wikipedia

Wikipedia

author：comprehensive 2025-10-02 03:34:40 Page View：69799

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DeSantis says Trump could've 'come out more forcefully' during Jan. 6
Next article： Novavax promises a turnaround & Lilly roils the obesity market

knowledge

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

AdobeSometimes,anappleadayreallyisjustwhatthedoctorordered.Andforthepastseveralyears,organizationsli

US soldier in North Korean custody after crossing DMZ line

1:03UnitedNationsCommandsoldiersandaSouthKoreansoldierstandguardbeforeNorthKorea'sPanmonHallandthemi

Bright Health sells Medicare Advantage business to Molina

BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

FILE-RichardMoore,theChiefofBritain'sSecretIntelligenceService,alsoknownasMI6,answersquestionsafterg